Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling
Yafei Jiang(Shanghai Jiao Tong University), Zhengdong Cai(Shanghai First People's Hospital), Yingqi Hua(Shanghai Jiao Tong University), Zhuoying Wang(Shanghai Jiao Tong University), Xinmeng Jin(Shanghai Jiao Tong University), Yunqi Li(Chinese Academy of Sciences), Gangyang Wang(Shanghai Jiao Tong University), Jinzeng Wang(Shanxi University), Haoran Mu(Anhui Medical University), Mengkai Yang(Shanghai First People's Hospital), Tao Zhang(Fudan University), Song Xue(Shanxi Medical University), Xiaojun Ma(Advanced Cell Diagnostics (United States)), Zongyi Wang(Shanghai Jiao Tong University), Jing Han(Shanghai Jiao Tong University), Jing Xu(Shanghai Jiao Tong University), Ke Zeng(Shanghai Jiao Tong University), Yu Lv(Shanghai Cancer Institute), Wei Sun(Zhejiang Wanli University), Mingzhu Yin(Chongqing Cancer Hospital)
Cited by 24
Related Papers
Biochar supported nanoscale zerovalent iron composite used as persulfate activator for removing trichloroethylene
|Bioresource Technology|2014|600
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|436
Cloning and Pharmacological Characterization of a Fourth Histamine Receptor (H<sub>4</sub>) Expressed in Bone Marrow
|Molecular Pharmacology|2001|408
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
|Proceedings of the National Academy of Sciences|2007|358
Landscape of tumor-infiltrating T cell repertoire of human cancers
|Nature Genetics|2016|328